NAMS logo

NAMS Cash From Financing

Annual CFF

$8.91 M
-$382.99 M-97.73%

December 31, 2023


Summary


Performance

NAMS Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMScash flowmetrics:

Quarterly CFF

$58.00 K
-$4.60 M-98.75%

September 30, 2024


Summary


Performance

NAMS Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMScash flowmetrics:

TTM CFF

$202.90 M
-$128.00 K-0.06%

September 30, 2024


Summary


Performance

NAMS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAMScash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NAMS Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-97.7%-68.8%+2176.7%
3 y3 years-36.0%--
5 y5 years-36.0%--

NAMS Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.7%at low-100.0%-100.0%-0.9%+8382.3%
5 y5-year-97.7%at low-100.0%-100.0%-0.9%+8382.3%
alltimeall time-97.7%at low-100.0%-100.0%-0.9%+8382.3%

NewAmsterdam Pharma Company NV Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$58.00 K(-98.8%)
$202.90 M(-0.1%)
Jun 2024
-
$4.66 M(-97.6%)
$203.02 M(-0.8%)
Mar 2024
-
$198.18 M(>+9900.0%)
$204.70 M(+2196.9%)
Dec 2023
$8.91 M
$0.00(-100.0%)
$8.91 M(0.0%)
Sep 2023
-
$186.00 K(-97.1%)
$8.91 M(+2.1%)
DateAnnualQuarterlyTTM
Jun 2023
-
$6.33 M(+164.8%)
$8.73 M(+264.8%)
Mar 2023
-
$2.39 M
$2.39 M
Dec 2022
$391.90 M(+362.7%)
-
-
Dec 2021
$84.70 M(+508.4%)
-
-
Dec 2020
$13.92 M
-
-

FAQ

  • What is NewAmsterdam Pharma Company NV annual cash flow from financing activities?
  • What is the all time high annual CFF for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV annual CFF year-on-year change?
  • What is NewAmsterdam Pharma Company NV quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV quarterly CFF year-on-year change?
  • What is NewAmsterdam Pharma Company NV TTM cash flow from financing activities?
  • What is the all time high TTM CFF for NewAmsterdam Pharma Company NV?
  • What is NewAmsterdam Pharma Company NV TTM CFF year-on-year change?

What is NewAmsterdam Pharma Company NV annual cash flow from financing activities?

The current annual CFF of NAMS is $8.91 M

What is the all time high annual CFF for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high annual cash flow from financing activities is $391.90 M

What is NewAmsterdam Pharma Company NV annual CFF year-on-year change?

Over the past year, NAMS annual cash flow from financing activities has changed by -$382.99 M (-97.73%)

What is NewAmsterdam Pharma Company NV quarterly cash flow from financing activities?

The current quarterly CFF of NAMS is $58.00 K

What is the all time high quarterly CFF for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high quarterly cash flow from financing activities is $198.18 M

What is NewAmsterdam Pharma Company NV quarterly CFF year-on-year change?

Over the past year, NAMS quarterly cash flow from financing activities has changed by -$128.00 K (-68.82%)

What is NewAmsterdam Pharma Company NV TTM cash flow from financing activities?

The current TTM CFF of NAMS is $202.90 M

What is the all time high TTM CFF for NewAmsterdam Pharma Company NV?

NewAmsterdam Pharma Company NV all-time high TTM cash flow from financing activities is $204.70 M

What is NewAmsterdam Pharma Company NV TTM CFF year-on-year change?

Over the past year, NAMS TTM cash flow from financing activities has changed by +$193.98 M (+2176.66%)